Meta Biomed Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Meta Biomed.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment earnings growth	40.9%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

No updates

Recent updates

Earnings Tell The Story For Meta Biomed Co., Ltd. (KOSDAQ:059210) As Its Stock Soars 30%

Feb 26

Here's How We Evaluate Meta Biomed Co., Ltd.'s (KOSDAQ:059210) Dividend

Apr 11

Meta Biomed's (KOSDAQ:059210) Stock Price Has Reduced 58% In The Past Five Years

Mar 14

Are Meta Biomed's (KOSDAQ:059210) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Feb 21

Meta Biomed (KOSDAQ:059210) Share Prices Have Dropped 22% In The Last Five Years

Dec 08

Meta Biomed Co., Ltd.'s (KOSDAQ:059210) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Nov 20

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Meta Biomed has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KOSDAQ:A059210 - Analysts future estimates and past financials data (KRW Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2023	83,101	10,292	-1,277	10,217	N/A
9/30/2023	79,545	7,360	-6,241	9,632	N/A
6/30/2023	77,747	3,715	-10,070	7,265	N/A
3/31/2023	75,428	5,399	-1,964	5,952	N/A
12/31/2022	68,942	1,874	-6,150	9,159	N/A
9/30/2022	66,883	7,127	1,072	10,295	N/A
6/30/2022	61,372	8,604	5,793	11,763	N/A
3/31/2022	60,795	8,832	1,934	14,655	N/A
12/31/2021	58,780	9,381	9,036	11,136	N/A
9/30/2021	54,183	4,490	7,356	9,437	N/A
6/30/2021	51,861	4,196	5,672	7,628	N/A
3/31/2021	45,793	-1,093	1,638	3,950	N/A
12/31/2020	44,998	-3,091	1,810	4,862	N/A
9/30/2020	46,823	2,035	227	4,486	N/A
6/30/2020	49,075	1,980	-4,191	1,810	N/A
3/31/2020	56,034	5,445	-5,291	1,411	N/A
12/31/2019	59,391	5,527	-5,204	2,865	N/A
9/30/2019	52,268	156	-5,122	2,248	N/A
6/30/2019	53,192	64	-28,883	-20,263	N/A
3/31/2019	51,518	-1,435	-8,893	-1,167	N/A
12/31/2018	52,586	953	-16,163	-5,283	N/A
9/30/2018	64,158	-4,131	-24,772	-8,173	N/A
6/30/2018	65,530	-2,666	-1,417	14,076	N/A
3/31/2018	66,563	-2,753	-18,429	-3,204	N/A
12/31/2017	65,341	-4,104	-11,313	-249	N/A
9/30/2017	66,531	262	N/A	3,853	N/A
6/30/2017	64,329	-635	N/A	6,498	N/A
3/31/2017	64,383	761	N/A	6,642	N/A
12/31/2016	65,784	639	N/A	5,033	N/A
9/30/2016	65,639	2,240	N/A	4,703	N/A
6/30/2016	67,236	1,476	N/A	2,429	N/A
3/31/2016	68,227	322	N/A	2,279	N/A
12/31/2015	68,592	806	N/A	4,933	N/A
9/30/2015	67,332	-2,369	N/A	2,626	N/A
6/30/2015	66,230	-3,088	N/A	964	N/A
3/31/2015	63,748	-4,242	N/A	962	N/A
12/31/2014	61,365	-4,952	N/A	-296	N/A
9/30/2014	58,403	-1,117	N/A	1,496	N/A
6/30/2014	59,885	-619	N/A	3,648	N/A
3/31/2014	63,423	1,752	N/A	4,627	N/A
12/31/2013	63,518	1,967	N/A	3,712	N/A
9/30/2013	65,701	2,844	N/A	5,569	N/A
6/30/2013	62,564	3,418	N/A	4,558	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if A059210's forecast earnings growth is above the savings rate (2.5%).

Earnings vs Market: Insufficient data to determine if A059210's earnings are forecast to grow faster than the KR market

High Growth Earnings: Insufficient data to determine if A059210's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if A059210's revenue is forecast to grow faster than the KR market.

High Growth Revenue: Insufficient data to determine if A059210's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if A059210's Return on Equity is forecast to be high in 3 years time

Meta Biomed Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Recent updates

Earnings Tell The Story For Meta Biomed Co., Ltd. (KOSDAQ:059210) As Its Stock Soars 30%

Investor sentiment improves as stock rises 19%

Upcoming dividend of ₩20.00 per share at 0.5% yield

New minor risk - Share price stability

Investor sentiment improves as stock rises 29%

Investor sentiment deteriorates as stock falls 17%

Investor sentiment improves as stock rises 15%

New major risk - Share price stability

Investor sentiment improves as stock rises 15%

Investor sentiment improves as stock rises 26%

Upcoming dividend of ₩20.00 per share

No independent directors

Investor sentiment deteriorated over the past week

No independent directors

Investor sentiment deteriorated over the past week

Upcoming dividend of ₩10.00 per share

Third quarter 2021 earnings released: EPS ₩43.00 (vs ₩29.00 in 3Q 2020)

Here's How We Evaluate Meta Biomed Co., Ltd.'s (KOSDAQ:059210) Dividend

Meta Biomed's (KOSDAQ:059210) Stock Price Has Reduced 58% In The Past Five Years

New 90-day low: ₩2,600

Are Meta Biomed's (KOSDAQ:059210) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Can Meta Biomed (KOSDAQ:059210) Continue To Grow Its Returns On Capital?

Is Meta Biomed (KOSDAQ:059210) A Risky Investment?

Here's Why I Think Meta Biomed (KOSDAQ:059210) Is An Interesting Stock

New 90-day high: ₩3,050

Meta Biomed (KOSDAQ:059210) Share Prices Have Dropped 22% In The Last Five Years

Meta Biomed Co., Ltd.'s (KOSDAQ:059210) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

New 90-day high - ₩3,175

New 90-day high - ₩2,890

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies